19-norandrostenedione has been researched along with 17-methylandrost-2-en-17-ol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bolt, HM; Degen, GH; Diel, P; Dorn, SB; Thevis, M | 1 |
| Bloch, W; Diel, P; Frese, S; Schänzer, W; Schleipen, B; Velders, M | 1 |
2 other study(ies) available for 19-norandrostenedione and 17-methylandrost-2-en-17-ol
| Article | Year |
|---|---|
Micronucleus induction in V79 cells by the anabolic doping steroids desoxymethyltestosterone (madol) and 19-norandrostenedione.
Topics: Anabolic Agents; Androstenedione; Androstenols; Animals; Apoptosis; Camptothecin; Cell Division; Cell Line; Doping in Sports; Dose-Response Relationship, Drug; Fibroblasts; G2 Phase; Hydrogen Peroxide; Methyl Methanesulfonate; Micronuclei, Chromosome-Defective; Micronucleus Tests; Microscopy, Fluorescence; Molecular Structure; Mutagens; Reactive Oxygen Species; S Phase | 2008 |
Myosin heavy chain expression pattern as a marker for anabolic potency: desoxymethyltestosterone (madol), norandrostenedione and testosterone repress MHC-IIb expression and stimulate MHC-IId/x expression in orchiectomized rat gastrocnemius muscle.
Topics: Anabolic Agents; Androgens; Androstenedione; Androstenols; Animals; Biomarkers; Designer Drugs; Down-Regulation; Hindlimb; Male; Molecular Weight; Muscle Fibers, Skeletal; Muscle, Skeletal; Myosin Heavy Chains; Orchiectomy; Organ Size; Protein Isoforms; Random Allocation; Rats; Rats, Wistar; Testosterone Propionate; Up-Regulation | 2011 |